tiprankstipranks
Trending News
More News >
Penumbra Inc. (PEN)
:PEN
US Market

Penumbra (PEN) Stock Forecast & Price Target

Compare
465 Followers
See the Price Targets and Ratings of:

PEN Analyst Ratings

Strong Buy
13Ratings
Strong Buy
10 Buy
3 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Penumbra
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PEN Stock 12 Month Forecast

Average Price Target

$307.92
▲(7.24% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Penumbra in the last 3 months. The average price target is $307.92 with a high forecast of $355.00 and a low forecast of $266.00. The average price target represents a 7.24% change from the last price of $287.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"226":"$226","291":"$291","356":"$356","258.5":"$258.5","323.5":"$323.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":355,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$355.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":307.92,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$307.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":266,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$266.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[226,258.5,291,323.5,356],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.66,296.5323076923077,301.4046153846154,306.2769230769231,311.14923076923077,316.02153846153846,320.8938461538462,325.7661538461539,330.63846153846157,335.51076923076926,340.38307692307694,345.2553846153846,350.1276923076923,{"y":355,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.66,292.91076923076923,294.1615384615385,295.4123076923077,296.66307692307697,297.9138461538462,299.1646153846154,300.41538461538465,301.66615384615386,302.91692307692307,304.16769230769233,305.41846153846154,306.6692307692308,{"y":307.92,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,291.66,289.68615384615384,287.7123076923077,285.73846153846154,283.7646153846154,281.79076923076923,279.8169230769231,277.8430769230769,275.8692307692308,273.8953846153846,271.9215384615385,269.9476923076923,267.9738461538461,{"y":266,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":244.84,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":237.48,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":266.97,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":285.44,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.13,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.82,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":250.68,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":243.01,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":269.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.63,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":227.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.66,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$355.00Average Price Target$307.92Lowest Price Target$266.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on PEN
Bank of America Securities
Bank of America Securities
$320
Buy
11.44%
Upside
Reiterated
12/08/25
Bank of America Securities Remains a Buy on Penumbra (PEN)
UBS
$335
Buy
16.67%
Upside
Reiterated
11/25/25
Penumbra (PEN) Gets a Buy from UBSValuation: Reiterate Buy on PEN, $335 PT. We reiterate our Buy rating and $335 PT which is derived by applying a 7x multiple (unchanged) on our rolled forward, revised Q5-Q8 estimates.
William Blair Analyst forecast on PEN
William Blair
William Blair
Buy
Reiterated
11/19/25
Penumbra's Promising Growth: Buy Rating Backed by STORM-PE Trial and Market ExpansionWednesday, November 19, 2025 4:09 PM William Blair Equity Research | Healthcare Penumbra, Inc.
Truist Financial Analyst forecast on PEN
Truist Financial
Truist Financial
$300$312
Buy
8.66%
Upside
Reiterated
11/06/25
Truist Financial Sticks to Its Buy Rating for Penumbra (PEN)
J.P. Morgan Analyst forecast on PEN
J.P. Morgan
J.P. Morgan
$265$275
Hold
-4.23%
Downside
Reiterated
11/06/25
Penumbra price target raised to $275 from $265 at JPMorganPenumbra price target raised to $275 from $265 at JPMorgan
Canaccord Genuity Analyst forecast on PEN
Canaccord Genuity
Canaccord Genuity
$350$355
Buy
23.63%
Upside
Reiterated
11/06/25
Penumbra price target raised to $355 from $350 at CanaccordPenumbra price target raised to $355 from $350 at Canaccord
Morgan Stanley Analyst forecast on PEN
Morgan Stanley
Morgan Stanley
$266
Hold
-7.36%
Downside
Reiterated
11/06/25
Penumbra's Hold Rating: Balancing Recent Success with Future Uncertainties
Evercore ISI Analyst forecast on PEN
Evercore ISI
Evercore ISI
$285$286
Buy
-0.40%
Downside
Reiterated
11/06/25
Penumbra (PEN) Gets a Buy from Evercore ISI
Needham
$326
Buy
13.53%
Upside
Reiterated
11/06/25
Penumbra's Strong Financial Performance and Strategic Advancements Reinforce Buy Ratingwe reiterate our Buy rating
BTIG
$320
Buy
11.44%
Upside
Reiterated
11/06/25
BTIG Reaffirms Their Buy Rating on Penumbra (PEN)
RBC Capital
$325
Buy
13.19%
Upside
Reiterated
11/05/25
RBC Capital Remains a Buy on Penumbra (PEN)
Citi
$285
Hold
-0.75%
Downside
Reiterated
10/21/25
Citi Remains a Hold on Penumbra (PEN)We rate PEN Neutral.
Wells Fargo Analyst forecast on PEN
Wells Fargo
Wells Fargo
$290
Buy
1.00%
Upside
Reiterated
10/01/25
Penumbra added to Q4 2025 Tactical Ideas List at Wells FargoPenumbra added to Q4 2025 Tactical Ideas List at Wells Fargo
Leerink Partners Analyst forecast on PEN
Leerink Partners
Leerink Partners
$327
Buy
13.88%
Upside
Reiterated
07/30/25
Penumbra's Strong Growth Potential and Strategic Developments Reinforce Buy RatingWe are reiterating our Outperform rating on PEN and maintaining our $327 PT following the company's 2Q results. PEN reported WW sales +4% vs. consensus, with WW Thrombectomy +1% vs. consensus and WW E&A sales +11% vs. consensus. We were particularly encouraged by another consecutive quarter of strong growth in VTE, with PEN's US VTE business growing +42% y/y. MSD growth of PEN's US Stroke business came in a bit soft, with the company citing flat market growth, though our sense is that expectations were low coming into the print. Notably, PEN announced an expansion of its sales force, including the addition of new E&A reps while existing reps focus more exclusively on PEN's thrombectomy business.
Nephron
$305
Buy
6.22%
Upside
Upgraded
07/30/25
Positive Report for Penumbra (PEN) from Nephron
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on PEN
Bank of America Securities
Bank of America Securities
$320
Buy
11.44%
Upside
Reiterated
12/08/25
Bank of America Securities Remains a Buy on Penumbra (PEN)
UBS
$335
Buy
16.67%
Upside
Reiterated
11/25/25
Penumbra (PEN) Gets a Buy from UBSValuation: Reiterate Buy on PEN, $335 PT. We reiterate our Buy rating and $335 PT which is derived by applying a 7x multiple (unchanged) on our rolled forward, revised Q5-Q8 estimates.
William Blair Analyst forecast on PEN
William Blair
William Blair
Buy
Reiterated
11/19/25
Penumbra's Promising Growth: Buy Rating Backed by STORM-PE Trial and Market ExpansionWednesday, November 19, 2025 4:09 PM William Blair Equity Research | Healthcare Penumbra, Inc.
Truist Financial Analyst forecast on PEN
Truist Financial
Truist Financial
$300$312
Buy
8.66%
Upside
Reiterated
11/06/25
Truist Financial Sticks to Its Buy Rating for Penumbra (PEN)
J.P. Morgan Analyst forecast on PEN
J.P. Morgan
J.P. Morgan
$265$275
Hold
-4.23%
Downside
Reiterated
11/06/25
Penumbra price target raised to $275 from $265 at JPMorganPenumbra price target raised to $275 from $265 at JPMorgan
Canaccord Genuity Analyst forecast on PEN
Canaccord Genuity
Canaccord Genuity
$350$355
Buy
23.63%
Upside
Reiterated
11/06/25
Penumbra price target raised to $355 from $350 at CanaccordPenumbra price target raised to $355 from $350 at Canaccord
Morgan Stanley Analyst forecast on PEN
Morgan Stanley
Morgan Stanley
$266
Hold
-7.36%
Downside
Reiterated
11/06/25
Penumbra's Hold Rating: Balancing Recent Success with Future Uncertainties
Evercore ISI Analyst forecast on PEN
Evercore ISI
Evercore ISI
$285$286
Buy
-0.40%
Downside
Reiterated
11/06/25
Penumbra (PEN) Gets a Buy from Evercore ISI
Needham
$326
Buy
13.53%
Upside
Reiterated
11/06/25
Penumbra's Strong Financial Performance and Strategic Advancements Reinforce Buy Ratingwe reiterate our Buy rating
BTIG
$320
Buy
11.44%
Upside
Reiterated
11/06/25
BTIG Reaffirms Their Buy Rating on Penumbra (PEN)
RBC Capital
$325
Buy
13.19%
Upside
Reiterated
11/05/25
RBC Capital Remains a Buy on Penumbra (PEN)
Citi
$285
Hold
-0.75%
Downside
Reiterated
10/21/25
Citi Remains a Hold on Penumbra (PEN)We rate PEN Neutral.
Wells Fargo Analyst forecast on PEN
Wells Fargo
Wells Fargo
$290
Buy
1.00%
Upside
Reiterated
10/01/25
Penumbra added to Q4 2025 Tactical Ideas List at Wells FargoPenumbra added to Q4 2025 Tactical Ideas List at Wells Fargo
Leerink Partners Analyst forecast on PEN
Leerink Partners
Leerink Partners
$327
Buy
13.88%
Upside
Reiterated
07/30/25
Penumbra's Strong Growth Potential and Strategic Developments Reinforce Buy RatingWe are reiterating our Outperform rating on PEN and maintaining our $327 PT following the company's 2Q results. PEN reported WW sales +4% vs. consensus, with WW Thrombectomy +1% vs. consensus and WW E&A sales +11% vs. consensus. We were particularly encouraged by another consecutive quarter of strong growth in VTE, with PEN's US VTE business growing +42% y/y. MSD growth of PEN's US Stroke business came in a bit soft, with the company citing flat market growth, though our sense is that expectations were low coming into the print. Notably, PEN announced an expansion of its sales force, including the addition of new E&A reps while existing reps focus more exclusively on PEN's thrombectomy business.
Nephron
$305
Buy
6.22%
Upside
Upgraded
07/30/25
Positive Report for Penumbra (PEN) from Nephron
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Penumbra

1 Month
xxx
Success Rate
18/24 ratings generated profit
75%
Average Return
+7.92%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +7.92% per trade.
3 Months
xxx
Success Rate
15/24 ratings generated profit
63%
Average Return
+7.40%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +7.40% per trade.
1 Year
Success Rate
19/24 ratings generated profit
79%
Average Return
+20.92%
reiterated a buy rating last month
Copying Shagun Singh Chadha's trades and holding each position for 1 Year would result in 79.17% of your transactions generating a profit, with an average return of +20.92% per trade.
2 Years
xxx
Success Rate
21/24 ratings generated profit
88%
Average Return
+23.29%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +23.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PEN Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
25
28
27
35
31
Hold
7
8
2
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
36
29
39
34
In the current month, PEN has received 31 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. PEN average Analyst price target in the past 3 months is 307.92.
Each month's total comprises the sum of three months' worth of ratings.

PEN Financial Forecast

PEN Earnings Forecast

Next quarter’s earnings estimate for PEN is $1.09 with a range of $0.99 to $1.24. The previous quarter’s EPS was $0.97. PEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.
Next quarter’s earnings estimate for PEN is $1.09 with a range of $0.99 to $1.24. The previous quarter’s EPS was $0.97. PEN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.

PEN Sales Forecast

Next quarter’s sales forecast for PEN is $362.22M with a range of $358.96M to $368.64M. The previous quarter’s sales results were $354.69M. PEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.
Next quarter’s sales forecast for PEN is $362.22M with a range of $358.96M to $368.64M. The previous quarter’s sales results were $354.69M. PEN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year PEN has Performed in-line its overall industry.

PEN Stock Forecast FAQ

What is PEN’s average 12-month price target, according to analysts?
Based on analyst ratings, Penumbra Inc.’s 12-month average price target is 307.92.
    What is PEN’s upside potential, based on the analysts’ average price target?
    Penumbra Inc. has 7.24% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PEN a Buy, Sell or Hold?
          Penumbra Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Penumbra Inc.’s price target?
            The average price target for Penumbra Inc. is 307.92. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $355.00 ,the lowest forecast is $266.00. The average price target represents 7.24% Increase from the current price of $287.14.
              What do analysts say about Penumbra Inc.?
              Penumbra Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of PEN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.